<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01345227</url>
  </required_header>
  <id_info>
    <org_study_id>BMT1</org_study_id>
    <nct_id>NCT01345227</nct_id>
  </id_info>
  <brief_title>Bone Marrow as an Alternative Site for Islet Transplantation</brief_title>
  <official_title>Pilot Study to Assess Feasibility and Safety of Bone Marrow as Alternative Site in Islet Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ospedale San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate safety and feasibility of bone marrow (BM) as site for
      islet transplantation (Tx) in humans. The investigators hypothesis is that BM represents a
      better site than liver thanks to its potential capacity to favor islet engraftment in face of
      a more easiness of access and bioptic follow up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We were permitted to perform single intra BM islet infusion at the level of the iliac crest
      in patients having contraindications for intraportal infusion. A needle for BM aspiration (14
      G) is inserted into the superior-posterior iliac crest and islet suspension (1:2.5;
      tissue:Ringer's Lactate solution) is infused. The entire intraBM-injection procedure lasted
      8-15 min from the beginning of anaesthesia (short propofol sedation).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse events related to the procedure of intra bone marrow islet infusion</measure>
    <time_frame>up to 3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beta-cell function</measure>
    <time_frame>up to 3 years</time_frame>
    <description>Beta-cell function will be assessed by fasting C peptide, HbA1c,glycaemia, change in average daily insulin requirements, basal (fasting) and -10 to 120 min time course of glucose, C-peptide and insulin derived from the arginine test, beta-score and Transplant Estimated Function</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Postpancreatectomy Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>Intra BM islet infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single intra BM islet infusion at the level of the iliac crest will be performed in patients having contraindications for intraportal infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intra bone marrow islet infusion</intervention_name>
    <description>A needle for bone marrow aspiration (14 G) will be inserted into the superior-posterior iliac crest and islet suspension (1:2.5; tissue:Ringer's Lactate solution) will be infused. The entire intraBM-injection procedure last 8-15 min from the beginning of anaesthesia (short propofol sedation).</description>
    <arm_group_label>Intra BM islet infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diabetic patients eligible for pancreatic islet transplantation based on local
             accepted practice and guidelines. This includes at least: a)clinical history
             compatible with T1D with insulin-dependence for &gt;5 years; b) undetectable stimulated
             (arginine or MMTT) C-peptide levels (&lt;0.3 ng/mL) in the 12 months before transplant
             c)presence of severe hypoglycaemic events

          -  patients undergoing total pancreatectomy because of anastomosis leakage after
             pancreatoduodenectomy or because of pancreatic anastomosis is made impracticable by
             technical difficulties and/or high risk of leakage.

          -  presence of contraindications for intraportal islet infusion

        Exclusion Criteria:

          -  presence of hematologic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorenzo Piemonti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Centro San Raffaele del Monte Tabor</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paola Maffi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Fondazione Centro San Raffaele del Monte Tabor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS San Raffaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Cantarelli E, Melzi R, Mercalli A, Sordi V, Ferrari G, Lederer CW, Mrak E, Rubinacci A, Ponzoni M, Sitia G, Guidotti LG, Bonifacio E, Piemonti L. Bone marrow as an alternative site for islet transplantation. Blood. 2009 Nov 12;114(20):4566-74. doi: 10.1182/blood-2009-03-209973. Epub 2009 Sep 22.</citation>
    <PMID>19773545</PMID>
  </reference>
  <reference>
    <citation>Ciceri F, Piemonti L. Bone marrow and pancreatic islets: an old story with new perspectives. Cell Transplant. 2010;19(12):1511-22. doi: 10.3727/096368910X514279. Epub 2010 Aug 17. Review.</citation>
    <PMID>20719074</PMID>
  </reference>
  <results_reference>
    <citation>Maffi P, Balzano G, Ponzoni M, Nano R, Sordi V, Melzi R, Mercalli A, Scavini M, Esposito A, Peccatori J, Cantarelli E, Messina C, Bernardi M, Del Maschio A, Staudacher C, Doglioni C, Ciceri F, Secchi A, Piemonti L. Autologous pancreatic islet transplantation in human bone marrow. Diabetes. 2013 Oct;62(10):3523-31. doi: 10.2337/db13-0465. Epub 2013 Jun 3. Erratum in: Diabetes. 2014 Jan;63(1):377.</citation>
    <PMID>23733196</PMID>
  </results_reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2011</study_first_submitted>
  <study_first_submitted_qc>April 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2011</study_first_posted>
  <last_update_submitted>March 4, 2015</last_update_submitted>
  <last_update_submitted_qc>March 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale San Raffaele</investigator_affiliation>
    <investigator_full_name>Piemonti Lorenzo</investigator_full_name>
    <investigator_title>Director Islet Transplantation Program</investigator_title>
  </responsible_party>
  <keyword>Type 1 diabetes</keyword>
  <keyword>islet transplantation</keyword>
  <keyword>autotransplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

